[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Remicade Biosimilar Sales Market Report 2017

February 2017 | 127 pages | ID: G8EBAA1B11AEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Remicade Biosimilar

Revenue, means the sales value of Remicade Biosimilar

This report studies sales (consumption) of Remicade Biosimilar in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Teva Pharmaceutical Industries
  • Synthon Pharmaceuticals
  • LG Life Sciences
  • Novartis (Sandoz)
  • Celltrion
  • Biocon
  • Hospira
  • Merck Serono (Merck Group)
  • Biogen idec Inc.
  • Genentech (Roche Group)
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Remicade Biosimilar in these regions, from 2011 to 2021 (forecast), like
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
  • 100mg/10ml
  • 500mg/50ml
Split by applications, this report focuses on sales, market share and growth rate of Remicade Biosimilar in each application, can be divided into
  • Blood Disorders
  • Oncology Diseases
Global Remicade Biosimilar Sales Market Report 2017

1 REMICADE BIOSIMILAR OVERVIEW

1.1 Product Overview and Scope of Remicade Biosimilar
1.2 Classification of Remicade Biosimilar
  1.2.1 100mg/10ml
  1.2.2 500mg/50ml
1.3 Application of Remicade Biosimilar
  1.3.1 Blood Disorders
  1.3.2 Oncology Diseases
1.4 Remicade Biosimilar Market by Regions
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Remicade Biosimilar (2012-2022)
  1.5.1 Global Remicade Biosimilar Sales and Growth Rate (2012-2022)
  1.5.2 Global Remicade Biosimilar Revenue and Growth Rate (2012-2022)

2 GLOBAL REMICADE BIOSIMILAR COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Remicade Biosimilar Market Competition by Manufacturers
  2.1.1 Global Remicade Biosimilar Sales and Market Share of Key Manufacturers (2012-2017)
  2.1.2 Global Remicade Biosimilar Revenue and Share by Manufacturers (2012-2017)
2.2 Global Remicade Biosimilar (Volume and Value) by Type
  2.2.1 Global Remicade Biosimilar Sales and Market Share by Type (2012-2017)
  2.2.2 Global Remicade Biosimilar Revenue and Market Share by Type (2012-2017)
2.3 Global Remicade Biosimilar (Volume and Value) by Regions
  2.3.1 Global Remicade Biosimilar Sales and Market Share by Regions (2012-2017)
  2.3.2 Global Remicade Biosimilar Revenue and Market Share by Regions (2012-2017)
2.4 Global Remicade Biosimilar (Volume) by Application

3 UNITED STATES REMICADE BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

3.1 United States Remicade Biosimilar Sales and Value (2012-2017)
  3.1.1 United States Remicade Biosimilar Sales and Growth Rate (2012-2017)
  3.1.2 United States Remicade Biosimilar Revenue and Growth Rate (2012-2017)
  3.1.3 United States Remicade Biosimilar Sales Price Trend (2012-2017)
3.2 United States Remicade Biosimilar Sales and Market Share by Manufacturers
3.3 United States Remicade Biosimilar Sales and Market Share by Type
3.4 United States Remicade Biosimilar Sales and Market Share by Application

4 CHINA REMICADE BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

4.1 China Remicade Biosimilar Sales and Value (2012-2017)
  4.1.1 China Remicade Biosimilar Sales and Growth Rate (2012-2017)
  4.1.2 China Remicade Biosimilar Revenue and Growth Rate (2012-2017)
  4.1.3 China Remicade Biosimilar Sales Price Trend (2012-2017)
4.2 China Remicade Biosimilar Sales and Market Share by Manufacturers
4.3 China Remicade Biosimilar Sales and Market Share by Type
4.4 China Remicade Biosimilar Sales and Market Share by Application

5 EUROPE REMICADE BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Remicade Biosimilar Sales and Value (2012-2017)
  5.1.1 Europe Remicade Biosimilar Sales and Growth Rate (2012-2017)
  5.1.2 Europe Remicade Biosimilar Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Remicade Biosimilar Sales Price Trend (2012-2017)
5.2 Europe Remicade Biosimilar Sales and Market Share by Manufacturers
5.3 Europe Remicade Biosimilar Sales and Market Share by Type
5.4 Europe Remicade Biosimilar Sales and Market Share by Application

6 JAPAN REMICADE BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Remicade Biosimilar Sales and Value (2012-2017)
  6.1.1 Japan Remicade Biosimilar Sales and Growth Rate (2012-2017)
  6.1.2 Japan Remicade Biosimilar Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Remicade Biosimilar Sales Price Trend (2012-2017)
6.2 Japan Remicade Biosimilar Sales and Market Share by Manufacturers
6.3 Japan Remicade Biosimilar Sales and Market Share by Type
6.4 Japan Remicade Biosimilar Sales and Market Share by Application

7 SOUTHEAST ASIA REMICADE BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Remicade Biosimilar Sales and Value (2012-2017)
  7.1.1 Southeast Asia Remicade Biosimilar Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Remicade Biosimilar Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Remicade Biosimilar Sales Price Trend (2012-2017)
7.2 Southeast Asia Remicade Biosimilar Sales and Market Share by Manufacturers
7.3 Southeast Asia Remicade Biosimilar Sales and Market Share by Type
7.4 Southeast Asia Remicade Biosimilar Sales and Market Share by Application

8 INDIA REMICADE BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

8.1 India Remicade Biosimilar Sales and Value (2012-2017)
  8.1.1 India Remicade Biosimilar Sales and Growth Rate (2012-2017)
  8.1.2 India Remicade Biosimilar Revenue and Growth Rate (2012-2017)
  8.1.3 India Remicade Biosimilar Sales Price Trend (2012-2017)
8.2 India Remicade Biosimilar Sales and Market Share by Manufacturers
8.3 India Remicade Biosimilar Sales and Market Share by Type
8.4 India Remicade Biosimilar Sales and Market Share by Application

9 GLOBAL REMICADE BIOSIMILAR MANUFACTURERS ANALYSIS

9.1 Teva Pharmaceutical Industries
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Remicade Biosimilar Product Type, Application and Specification
    9.1.2.1 100mg/10ml
    9.1.2.2 500mg/50ml
  9.1.3 Teva Pharmaceutical Industries Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Synthon Pharmaceuticals
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Remicade Biosimilar Product Type, Application and Specification
    9.2.2.1 100mg/10ml
    9.2.2.2 500mg/50ml
  9.2.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 LG Life Sciences
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Remicade Biosimilar Product Type, Application and Specification
    9.3.2.1 100mg/10ml
    9.3.2.2 500mg/50ml
  9.3.3 LG Life Sciences Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Novartis (Sandoz)
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Remicade Biosimilar Product Type, Application and Specification
    9.4.2.1 100mg/10ml
    9.4.2.2 500mg/50ml
  9.4.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Celltrion
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Remicade Biosimilar Product Type, Application and Specification
    9.5.2.1 100mg/10ml
    9.5.2.2 500mg/50ml
  9.5.3 Celltrion Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Biocon
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Remicade Biosimilar Product Type, Application and Specification
    9.6.2.1 100mg/10ml
    9.6.2.2 500mg/50ml
  9.6.3 Biocon Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Hospira
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Remicade Biosimilar Product Type, Application and Specification
    9.7.2.1 100mg/10ml
    9.7.2.2 500mg/50ml
  9.7.3 Hospira Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Merck Serono (Merck Group)
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Remicade Biosimilar Product Type, Application and Specification
    9.8.2.1 100mg/10ml
    9.8.2.2 500mg/50ml
  9.8.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Biogen idec Inc.
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Remicade Biosimilar Product Type, Application and Specification
    9.9.2.1 100mg/10ml
    9.9.2.2 500mg/50ml
  9.9.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Genentech (Roche Group)
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Remicade Biosimilar Product Type, Application and Specification
    9.10.2.1 100mg/10ml
    9.10.2.2 500mg/50ml
  9.10.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview

10 REMICADE BIOSIMILAR MAUFACTURING COST ANALYSIS

10.1 Remicade Biosimilar Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Remicade Biosimilar
10.3 Manufacturing Process Analysis of Remicade Biosimilar

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Remicade Biosimilar Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Remicade Biosimilar Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL REMICADE BIOSIMILAR MARKET FORECAST (2017-2022)

14.1 Global Remicade Biosimilar Sales, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Remicade Biosimilar Sales and Growth Rate Forecast (2017-2022)
  14.1.2 Global Remicade Biosimilar Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Remicade Biosimilar Price and Trend Forecast (2017-2022)
14.2 Global Remicade Biosimilar Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.1 United States Remicade Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.2 China Remicade Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.3 Europe Remicade Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 Japan Remicade Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Southeast Asia Remicade Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 India Remicade Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Remicade Biosimilar Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Remicade Biosimilar Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Remicade Biosimilar
Table Classification of Remicade Biosimilar
Figure Global Sales Market Share of Remicade Biosimilar by Type in 2015
Figure 100mg/10ml Picture
Figure 500mg/50ml Picture
Table Applications of Remicade Biosimilar
Figure Global Sales Market Share of Remicade Biosimilar by Application in 2015
Figure Blood Disorders Examples
Figure Oncology Diseases Examples
Figure United States Remicade Biosimilar Revenue and Growth Rate (2012-2022)
Figure China Remicade Biosimilar Revenue and Growth Rate (2012-2022)
Figure Europe Remicade Biosimilar Revenue and Growth Rate (2012-2022)
Figure Japan Remicade Biosimilar Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Remicade Biosimilar Revenue and Growth Rate (2012-2022)
Figure India Remicade Biosimilar Revenue and Growth Rate (2012-2022)
Figure Global Remicade Biosimilar Sales and Growth Rate (2012-2022)
Figure Global Remicade Biosimilar Revenue and Growth Rate (2012-2022)
Table Global Remicade Biosimilar Sales of Key Manufacturers (2012-2017)
Table Global Remicade Biosimilar Sales Share by Manufacturers (2012-2017)
Figure 2015 Remicade Biosimilar Sales Share by Manufacturers
Figure 2016 Remicade Biosimilar Sales Share by Manufacturers
Table Global Remicade Biosimilar Revenue by Manufacturers (2012-2017)
Table Global Remicade Biosimilar Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Remicade Biosimilar Revenue Share by Manufacturers
Table 2016 Global Remicade Biosimilar Revenue Share by Manufacturers
Table Global Remicade Biosimilar Sales and Market Share by Type (2012-2017)
Table Global Remicade Biosimilar Sales Share by Type (2012-2017)
Figure Sales Market Share of Remicade Biosimilar by Type (2012-2017)
Figure Global Remicade Biosimilar Sales Growth Rate by Type (2012-2017)
Table Global Remicade Biosimilar Revenue and Market Share by Type (2012-2017)
Table Global Remicade Biosimilar Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Remicade Biosimilar by Type (2012-2017)
Figure Global Remicade Biosimilar Revenue Growth Rate by Type (2012-2017)
Table Global Remicade Biosimilar Sales and Market Share by Regions (2012-2017)
Table Global Remicade Biosimilar Sales Share by Regions (2012-2017)
Figure Sales Market Share of Remicade Biosimilar by Regions (2012-2017)
Figure Global Remicade Biosimilar Sales Growth Rate by Regions (2012-2017)
Table Global Remicade Biosimilar Revenue and Market Share by Regions (2012-2017)
Table Global Remicade Biosimilar Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Remicade Biosimilar by Regions (2012-2017)
Figure Global Remicade Biosimilar Revenue Growth Rate by Regions (2012-2017)
Table Global Remicade Biosimilar Sales and Market Share by Application (2012-2017)
Table Global Remicade Biosimilar Sales Share by Application (2012-2017)
Figure Sales Market Share of Remicade Biosimilar by Application (2012-2017)
Figure Global Remicade Biosimilar Sales Growth Rate by Application (2012-2017)
Figure United States Remicade Biosimilar Sales and Growth Rate (2012-2017)
Figure United States Remicade Biosimilar Revenue and Growth Rate (2012-2017)
Figure United States Remicade Biosimilar Sales Price Trend (2012-2017)
Table United States Remicade Biosimilar Sales by Manufacturers (2012-2017)
Table United States Remicade Biosimilar Market Share by Manufacturers (2012-2017)
Table United States Remicade Biosimilar Sales by Type (2012-2017)
Table United States Remicade Biosimilar Market Share by Type (2012-2017)
Table United States Remicade Biosimilar Sales by Application (2012-2017)
Table United States Remicade Biosimilar Market Share by Application (2012-2017)
Figure China Remicade Biosimilar Sales and Growth Rate (2012-2017)
Figure China Remicade Biosimilar Revenue and Growth Rate (2012-2017)
Figure China Remicade Biosimilar Sales Price Trend (2012-2017)
Table China Remicade Biosimilar Sales by Manufacturers (2012-2017)
Table China Remicade Biosimilar Market Share by Manufacturers (2012-2017)
Table China Remicade Biosimilar Sales by Type (2012-2017)
Table China Remicade Biosimilar Market Share by Type (2012-2017)
Table China Remicade Biosimilar Sales by Application (2012-2017)
Table China Remicade Biosimilar Market Share by Application (2012-2017)
Figure Europe Remicade Biosimilar Sales and Growth Rate (2012-2017)
Figure Europe Remicade Biosimilar Revenue and Growth Rate (2012-2017)
Figure Europe Remicade Biosimilar Sales Price Trend (2012-2017)
Table Europe Remicade Biosimilar Sales by Manufacturers (2012-2017)
Table Europe Remicade Biosimilar Market Share by Manufacturers (2012-2017)
Table Europe Remicade Biosimilar Sales by Type (2012-2017)
Table Europe Remicade Biosimilar Market Share by Type (2012-2017)
Table Europe Remicade Biosimilar Sales by Application (2012-2017)
Table Europe Remicade Biosimilar Market Share by Application (2012-2017)
Figure Japan Remicade Biosimilar Sales and Growth Rate (2012-2017)
Figure Japan Remicade Biosimilar Revenue and Growth Rate (2012-2017)
Figure Japan Remicade Biosimilar Sales Price Trend (2012-2017)
Table Japan Remicade Biosimilar Sales by Manufacturers (2012-2017)
Table Japan Remicade Biosimilar Market Share by Manufacturers (2012-2017)
Table Japan Remicade Biosimilar Sales by Type (2012-2017)
Table Japan Remicade Biosimilar Market Share by Type (2012-2017)
Table Japan Remicade Biosimilar Sales by Application (2012-2017)
Table Japan Remicade Biosimilar Market Share by Application (2012-2017)
Figure Southeast Asia Remicade Biosimilar Sales and Growth Rate (2012-2017)
Figure Southeast Asia Remicade Biosimilar Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Remicade Biosimilar Sales Price Trend (2012-2017)
Table Southeast Asia Remicade Biosimilar Sales by Manufacturers (2012-2017)
Table Southeast Asia Remicade Biosimilar Market Share by Manufacturers (2012-2017)
Table Southeast Asia Remicade Biosimilar Sales by Type (2012-2017)
Table Southeast Asia Remicade Biosimilar Market Share by Type (2012-2017)
Table Southeast Asia Remicade Biosimilar Sales by Application (2012-2017)
Table Southeast Asia Remicade Biosimilar Market Share by Application (2012-2017)
Figure India Remicade Biosimilar Sales and Growth Rate (2012-2017)
Figure India Remicade Biosimilar Revenue and Growth Rate (2012-2017)
Figure India Remicade Biosimilar Sales Price Trend (2012-2017)
Table India Remicade Biosimilar Sales by Manufacturers (2012-2017)
Table India Remicade Biosimilar Market Share by Manufacturers (2012-2017)
Table India Remicade Biosimilar Sales by Type (2012-2017)
Table India Remicade Biosimilar Market Share by Type (2012-2017)
Table India Remicade Biosimilar Sales by Application (2012-2017)
Table India Remicade Biosimilar Market Share by Application (2012-2017)
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Remicade Biosimilar Global Market Share (2012-2017)
Table Synthon Pharmaceuticals Basic Information List
Table Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Synthon Pharmaceuticals Remicade Biosimilar Global Market Share (2012-2017)
Table LG Life Sciences Basic Information List
Table LG Life Sciences Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure LG Life Sciences Remicade Biosimilar Global Market Share (2012-2017)
Table Novartis (Sandoz) Basic Information List
Table Novartis (Sandoz) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis (Sandoz) Remicade Biosimilar Global Market Share (2012-2017)
Table Celltrion Basic Information List
Table Celltrion Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Celltrion Remicade Biosimilar Global Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biocon Remicade Biosimilar Global Market Share (2012-2017)
Table Hospira Basic Information List
Table Hospira Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hospira Remicade Biosimilar Global Market Share (2012-2017)
Table Merck Serono (Merck Group) Basic Information List
Table Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Serono (Merck Group) Remicade Biosimilar Global Market Share (2012-2017)
Table Biogen idec Inc. Basic Information List
Table Biogen idec Inc. Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biogen idec Inc. Remicade Biosimilar Global Market Share (2012-2017)
Table Genentech (Roche Group) Basic Information List
Table Genentech (Roche Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genentech (Roche Group) Remicade Biosimilar Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Remicade Biosimilar
Figure Manufacturing Process Analysis of Remicade Biosimilar
Figure Remicade Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Remicade Biosimilar Major Manufacturers in 2015
Table Major Buyers of Remicade Biosimilar
Table Distributors/Traders List
Figure Global Remicade Biosimilar Sales and Growth Rate Forecast (2017-2022)
Figure Global Remicade Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Table Global Remicade Biosimilar Sales Forecast by Regions (2017-2022)
Table Global Remicade Biosimilar Sales Forecast by Type (2017-2022)
Table Global Remicade Biosimilar Sales Forecast by Application (2017-2022)


More Publications